Shreeram Aradhye
Chief Tech/Sci/R&D Officer presso NOVARTIS AG
Profilo
Shreeram Aradhye is currently the Director at Valo Health LLC and the Chief Medical Officer & President-Development at Novartis AG.
Previously, he worked as the Chief Medical Officer & Executive Vice President at Dicerna Pharmaceuticals, Inc. and as the Chief Medical Officer at Novartis Pharmaceuticals Corp.
He also served as an Independent Director at Axcella Health, Inc. and as the Head-Global Clinical Development & Medical Affairs at Sandoz International GmbH.
Additionally, he was an Assistant Professor at the University of Pennsylvania.
Aradhye completed his undergraduate degree at the All India Institute of Medical Sciences.
Posizioni attive di Shreeram Aradhye
Società | Posizione | Inizio |
---|---|---|
NOVARTIS AG | Chief Tech/Sci/R&D Officer | 16/05/2022 |
Valo Health LLC
Valo Health LLC Packaged SoftwareTechnology Services Valo Health LLC operates as a drug discovery technology company. It offers cloud computing as well as longitudinal and human data to create an entirely new drug discovery and development process. The company was founded in 2019 and is headquartered in Boston, MA. | Director/Board Member | - |
Precedenti posizioni note di Shreeram Aradhye
Società | Posizione | Fine |
---|---|---|
AXCA HEALPAR | Director/Board Member | 19/05/2022 |
DICERNA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/03/2022 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Chief Tech/Sci/R&D Officer | 01/04/2019 |
Sandoz International GmbH
Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | Chief Tech/Sci/R&D Officer | 01/01/2011 |
University of Pennsylvania | Corporate Officer/Principal | - |
Formazione di Shreeram Aradhye
All India Institute of Medical Sciences | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
NOVARTIS AG | Health Technology |
AXCA HEALPAR | Health Technology |
Aziende private | 4 |
---|---|
Dicerna Pharmaceuticals, Inc.
Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to selectively silence genes that cause or contribute to disease. The firm uses its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas. The company was founded by Douglas M. Fambrough III, Mark A. Behlke, Roberto Guerciolini, James Craig Jenson, and John J. Rossi in October 2006 and is headquartered in Lexington, MA. | Health Technology |
Sandoz International GmbH
Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
Valo Health LLC
Valo Health LLC Packaged SoftwareTechnology Services Valo Health LLC operates as a drug discovery technology company. It offers cloud computing as well as longitudinal and human data to create an entirely new drug discovery and development process. The company was founded in 2019 and is headquartered in Boston, MA. | Technology Services |
- Borsa valori
- Insiders
- Shreeram Aradhye